10-Q
XBRL
QUARTERLY REPORT
- Company
- Compass Therapeutics, Inc.
- Filed
- February 14, 2019
- Period of Report
- December 31, 2018
- Accession Number
- 0001213900-19-002496
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →